To seek approval for a new specification for the steviol glycoside,rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract.The bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.

The purpose of this Application is to permit 2'-fucosyllactose (2'-FL), produced by microbial fermentation using genetically modified Escherichia coli (E.coli) strains, in infant formula products, follow-on formula and formulated supplementary foods for young children (FSFYC).

The purpose of this application is the addition of a new total dietary fibre method, AOAC 2017.16, as a permitted method in Schedule 11 of the Australia and New Zealand Food Standards Code.

This application seeks approval for a “β-Galactosidase (EC 3.2.1.23)' enzyme derived from a genetically modified organism for use as a processing aid in dairy food applications.

The purpose of this application is to amend the Food Standards Code to permit the
use of nicotinamide riboside chloride as a permitted form of Vitamin B3 in food
for special medical purposes (FSMPs).

This application sought approval to permit the sale of low-THC hemp leaf, seed sprout and root as food and food ingredients in Australia and New Zealand. It was withdrawn.
 

This application seeks approval to permit the use of a steviol glycoside mixture, Rebaudioside MD, that is produced by fermentation from a genetically modified Yarrowia lipolytica (Y. lipolytica), expressing steviol glycoside biosynthesis pathway genes, as an intense sweetener.

The purpose of the application is to extend the option of phytosanitary irradiation to all types of fresh fruits and vegetables.

Approval Report - 12 May 2021(PDF 456 kb) (Word 238 kb)